RxDoctor Payments Data

Taha Faruqi, DO

Orthopaedic Surgery of the Spine · Warrington, PANPI 1740636943

Payments from drug & device makers

What this record shows

This record is dominated by grants: $22,149 of the $33,500 with a category attached, or 66.1%. Globus Medical accounts for 75.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $26,187 and has fallen 93.4% since, to $1,741 in 2025.

$33,500in general payments, 2019–2025

Across 101 payments — averaging $331.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$25K
  • Medtronic$4K
  • Stryker$1K
  • VB Spine LLC$724
  • Pinnacle, Inc$617
  • Alphatec Spine, Inc$292
  • plus $1K from 15 others

What the payments were for

  • Grants$22,14966%
  • Travel & lodging$5,25916%
  • Food & beverage$5,48516%
  • Education$6072%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,500 in reported general payments places this provider in the 70th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$105,449
Medicare patients
393
Services billed
1,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone177$885
Celecoxib22$336
Meloxicam119$148
Methocarbamol37$93
Gabapentin32$53
Tramadol Hcl32$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Warrington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →